High-Throughput Biopharmaceutical Drug Development: Meeting the Coming Challenge

Many factors must be considered to overcome the challenges associated with viral clearance.

Collaboration between technology providers and biopharma manufacturers are enabling both evolutionary and novel developments.

Downstream processes may be streamlined by using automation.

Automation technologies used in the development and manufacture of biopharmaceuticals continue to evolve, providing the potential for reduced costs and time.

Freudenberg Medical now offers custom single-use assemblies to expand its offerings in silicone extrusion and molding for biopharma applications.

Ecolab Life Sciences and Repligen introduce DurA Cycle, a new affinity resin for large-scale biologics manufacturing.